Looking to the Future of Parenteral Packaging.

Pandemic Preparedness: Ensuring a Robust Parenteral Packaging Supply Chain.

For drug developers, being ready to develop and mass produce drugs for a pandemic situation is an essential part of their risk management strategy. But what about the packaging suppliers that create containers, stoppers, plungers, and seals to protect and deliver these vital drugs?

This webinar will discuss work that has been done to develop, manufacture, and distribute parenteral packaging components for the on-going COVID-19 pandemic, while also touching on the critical aspects to consider to prepare for a future pandemic or natural disaster scenario.

Topics of discussion will include

– An introduction to packaging components for vaccine applications

– An overview of common challenges that packaging suppliers face with manufacturing and distributing vaccines and how to overcome them

-Strategies for ensuring business continuity during disaster scenarios

Key learning objectives

– Understand the risks that the pharma industry faces when it comes to packaging vaccines in emergency scenarios and which actions to take to mitigate these risks.

– Learn steps to take to overcome manufacturing and distribution challenges for vaccine components.

– Learn from case studies and best practices about how to ensure business continuity during disaster scenarios

Who should attend

– Quality/regulatory personnel in parenteral drug delivery

– Formulation scientists and packaging engineers

– Device development engineers and managers

– Technical functions surrounding drug delivery systems

– Extractable and leachable experts

– Procurement professionals

Geert Moens holds a university degree in public administration. After working in the human resources domain, he joined Datwyler in 2007 and has more than a decade of experience within Datwyler as a key account manager responsible for strategic pharmaceutical accounts throughout Europe and beyond. In this role, he has developed a thorough insight in the landscape of pharmaceutical parenteral packaging components. In 2018, Geert became the strategic lead of Datwyler’s vial closure system components as a global platform leader, where he drives the product and service portfolio, product and service innovations, and formulates the market approach.